Creutzfeldt-Jakob disease after pituitary gonadotrophins.
作者信息
Healy D L, Evans J
出版信息
BMJ. 1993 Aug 28;307(6903):517-8. doi: 10.1136/bmj.307.6903.517.
Abstract
摘要
相似文献
1
Creutzfeldt-Jakob disease after pituitary gonadotrophins.
BMJ. 1993 Aug 28;307(6903):517-8. doi: 10.1136/bmj.307.6903.517.
2
Creutzfeldt-Jakob legacy for Australian women treated with human pituitary gonadotropins.
Lancet. 1992 Oct 3;340(8823):847-8. doi: 10.1016/0140-6736(92)92720-z.
3
Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin.
Aust N Z J Med. 1990 Aug;20(4):592-3. doi: 10.1111/j.1445-5994.1990.tb01322.x.
4
Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case.
J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1094-5. doi: 10.1136/jnnp.55.11.1094.
5
Transmission of Creutzfeldt-Jakob disease by investigative and therapeutic procedures.
Adverse Drug React Toxicol Rev. 1991 Summer;10(2):89-98.
6
Early infertility treatments derived from human pituitary.
BMJ. 1993 Apr 24;306(6885):1128-9. doi: 10.1136/bmj.306.6885.1128-b.
7
[A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
Ned Tijdschr Geneeskd. 1996 Jun 1;140(22):1190-3.
8
Prions, urinary gonadotrophins and recombinant gonadotrophins.
Hum Reprod. 2003 May;18(5):1129-30. doi: 10.1093/humrep/deg176.
9
[Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
Rev Neurol (Paris). 1992;148(5):328-34.
10
Consensus statement on the bio-safety of urinary-derived gonadotrophins with respect to Creutzfeldt-Jakob disease.
Hum Reprod. 2005 Nov;20(11):2994-9. doi: 10.1093/humrep/dei209. Epub 2005 Jul 29.
引用本文的文献
1
A profile of Bruno Lunenfeld, MD, FRCOG, FACOG (hon).
Am J Obstet Gynecol. 2018 Sep;219(3):225-234. doi: 10.1016/j.ajog.2018.06.019.
2
Inactivation of prions by acidic sodium dodecyl sulfate.
J Virol. 2006 Jan;80(1):322-31. doi: 10.1128/JVI.80.1.322-331.2006.
3
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9936-40. doi: 10.1073/pnas.91.21.9936.
4
Etiology and pathogenesis of prion diseases.
Am J Pathol. 1995 Apr;146(4):785-811.
本文引用的文献
1
Suspension of the Australian human pituitary hormone programme.
Med J Aust. 1985 Jul 22;143(2):57-9. doi: 10.5694/j.1326-5377.1985.tb122796.x.
2
Iatrogenic Creutzfeldt-Jakob disease.
Neurology. 1987 Sep;37(9):1520-2. doi: 10.1212/wnl.37.9.1520.
3
Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin.
Aust N Z J Med. 1990 Aug;20(4):592-3. doi: 10.1111/j.1445-5994.1990.tb01322.x.
4
A 'unified theory' of prion propagation.
Nature. 1991 Aug 22;352(6337):679-83. doi: 10.1038/352679a0.
5
Molecular biology of prion diseases.
Science. 1991 Jun 14;252(5012):1515-22. doi: 10.1126/science.1675487.
6
Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease.
Lancet. 1991 Jun 15;337(8755):1441-2. doi: 10.1016/0140-6736(91)93128-v.
7
Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease.
N Engl J Med. 1992 Aug 27;327(9):649. doi: 10.1056/NEJM199208273270918.
8
Untoward events in patients treated with growth hormone in the USA.
Horm Res. 1992;38 Suppl 1:44-9. doi: 10.1159/000182569.
Zotero 插件